In a study of 66 individuals treated during early primary HIV infection for up to three years, researchers observed persistent T-cell activation and elevated expression of immune checkpoint receptors such as PD1, Tim-3, and TIGIT, even with ART. This evidence concerns the gene HAVCR2 and HIV infectious disease.